Moolec Science Secures Nasdaq Exception, Boosts Equity by Over $100M via Subsidiary Derecognition
Summary
Moolec Science SA has received an exception from Nasdaq until June 29, 2026, to regain compliance with listing requirements, reporting an estimated increase of over $100 million in stockholders' equity due to the derecognition of bankrupt subsidiaries.
Key Events
-
Nasdaq Compliance Exception
Moolec Science SA received an exception from the Nasdaq Hearings Panel until June 29, 2026, to regain compliance with the stockholders' equity requirement, mitigating immediate delisting concerns.
-
Significant Equity Increase
The company reported an estimated increase of approximately $100.8 million in stockholders' equity, which it believes brings it into compliance with Nasdaq's listing rules.
-
Derecognition of Bankrupt Subsidiaries
This equity increase stems from accounting gains recognized due to the loss of control over subsidiaries Bioceres S.A., Bioceres LLC, and Theo I SCSp, following their bankruptcy proceedings in December 2025.
Analysis
The Nasdaq Hearings Panel granted Moolec Science an exception, extending its deadline to meet the stockholders' equity requirement until June 29, 2026. This temporary relief from potential delisting is a critical development for the company. Moolec believes it has already regained compliance, attributing an estimated $100.8 million increase in stockholders' equity to accounting gains from the derecognition of subsidiaries (Bioceres S.A., Bioceres LLC, and Theo I SCSp) following their respective bankruptcy proceedings. While the underlying bankruptcies of subsidiaries are negative operational events, the resulting accounting gains significantly improve Moolec's balance sheet and address a key listing compliance issue, providing a positive signal for the company's immediate future on Nasdaq.
At the time of this filing, MLEC was trading at $6.60 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $4.7M. The 52-week trading range was $3.08 to $157.05. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.